Clinical Trials

Advancing Cancer Care through Clinical Trials

Today, clinical trial research is no longer conducted exclusively at large university cancer centers or major metropolitan hospitals. Shenandoah Oncology has embraced clinical trial research as a critical component of community-based care for patients with cancer or blood disorders and is pleased to provide local patients access to cutting-edge and innovative clinical trials in a comfortable and convenient setting.

At Shenandoah Oncology we are dedicated to finding new and better ways to treat cancer through research and clinical trials. We have access to clinical trials through our affiliation with Sarah Cannon Research Institute (SCRI) and as a VCU Massey Comprehensive Cancer Center (VCU) clinical research affiliate​​​​​.

Our research program, SCRI at Shenandoah Oncology, provides access to the latest clinical trial options to people facing cancer and is part of an expansive research network with the goals of advancing therapies for patients and transforming cancer care within the community, where the majority of people seek cancer treatment. At any given time, SCRI at Shenandoah Oncology has many treatment clinical trials open in various disease types including breast, lung and solid tumor.

Participating in these clinical trials also allows us to provide valuable access to new investigational cancer agents to patients right here in their community. Our patients are able to access state-of-the-art investigational therapies, while their own physician directs and closely monitors their care. Patients are able to remain at home near family and loved ones.

Furthermore, our research network is also looking toward the future by developing initiatives in “personalized” or “individualized” medicine. These types of clinical trials offer the potential to recommend drug treatment based on the genetic makeup of the patient's tumor.

In addition, Shenandoah Oncology is a proud clinical research affiliate of VCU Massey Comprehensive Cancer Center. This program allows us to offer additional innovative therapies and clinical trials to our patients to help advance the science of cancer care while offering the best possible treatments and improved patient outcomes. If you would like more information, you may speak to your physician or our research department about the open clinical trials.